Maximum Strength Urinary Pain Relief Tablet
Product Images NDC 11673-270

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Maximum Strength Urinary Pain Relief (NDC 11673-270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Target Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Targetcorp1 (11673160 1)

Targetcorp1 (11673160 1)
This is a description of a maximum strength urinary pain relief tablet containing 99.5 mg of phenazopyridine hydrochloride, a urinary tract analgesic that provides relief for urinary pain and burning. The tablet is a generic equivalent to AZO Urinary Pain Relief Maximum Strength and is available without a prescription. This drug fact indicates that adults and children 12 years and over should take 2 tablets 3 times daily with or after meals for up to 2 days, with a maximum dose of 12 tablets. Notably, this product may interfere with laboratory tests, and may cause stomach upset and red/orange-colored urine. Pregnant or breastfeeding individuals should seek professional advice before using this medication. Contact a doctor if symptoms persist for more than 2 days or if there is any sign of adverse reactions. The product is distributed by Target Corp. Product of India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.